Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 7,076–7,100 of 27,380 studies, newest first · page 284 of 1096.

December 2023 25

  1. 2023-12-12

    Fatal iatrogenic cerebral β-amyloid-related arteritis in a woman treated with lecanemab for Alzheimer's disease

    ✓ Peer-reviewed Treatments Nature communications

    Key finding: Magnetic resonance imaging revealed she had multifocal swelling and a marked increase in the number of cerebral microhemorrhages. +2 more findings

  2. 2023-12-12

    Gridlock in hospital medicine

    ✓ Peer-reviewed Health systems and care delivery Journal of Hospital Medicine

    Key finding: Before the COVID-19 pandemic, supply and demand forcast models predicted significant nursing shortages across the United States through 2030 due to both an aging patient population and nursing workforce.1, 2 However, during the pandemic, we saw an exodus of younger nurses in addition to early retirements. +4 more findings

  3. 2023-12-11

    Addressing Overlapping Sample Challenges in Genome-Wide Association Studies: Meta-Reductive Approach

    ✓ Peer-reviewed Genetics PloS one

    Key finding: In this study, we present a novel methodology, Meta-Reductive Approach (MRA), that was derived algebraically to adjust GWAS results, aiming to neutralize the influence of select cohorts.

  4. 2023-12-11

    Blood Neurofilament Levels Predict Cognitive Decline across the Alzheimer's Disease Continuum

    ✓ Peer-reviewed Biomarkers International journal of molecular sciences

    Key finding: Neurofilament light chain (NfL) is a potential diagnostic and prognostic plasma biomarker for numerous neurological diseases including Alzheimer's disease (AD).

  5. 2023-12-11

    Plasma p-tau212: antemortem diagnostic performance and prediction of autopsy verification of Alzheimer's disease neuropathology

    ✓ Peer-reviewed Biomarkers Nature communications

    Key finding: These findings support plasma p-tau212 as a novel peripherally accessible biomarker of AD pathophysiology.

  6. 2023-12-09

    Disparate Dementia Risk Factors Are Associated with Cognitive Impairment and Rates of Decline in African Americans

    ✓ Peer-reviewed Risk factors Annals of Neurology

    Key finding: Hypertension, hypercholesterolemia, obesity, and diabetes were overrepresented in AA participants, but were not associated with cognitive impairment. +4 more findings

  7. 2023-12-08

    The clinical efficacy of Olibanum gum chewing in patients with Mild-to-Moderate Alzheimer disease: A randomized Parallel-Design controlled trial

    ✓ Peer-reviewed Treatments Neuropsychopharmacology reports

    Key finding: This study revealed that 18 weeks of gum chewing with Olibanum did not change the neuropsychological status. +4 more findings

  8. 2023-12-06

    Pathways linking microbiota-gut-brain axis with neuroinflammatory mechanisms in Alzheimer's pathophysiology

    ✓ Peer-reviewed Disease mechanisms Microbiome research reports

    Key finding: Growing evidence suggests the gut microbiome's crucial role in shaping the pathogenesis of AD by influencing inflammatory mediators. +4 more findings

  9. 2023-12-06

    Organ aging signatures in the plasma proteome track health and disease

    ✓ Peer-reviewed Biomarkers Nature

    Key finding: We discovered nearly 20% of the population show strongly accelerated age in one organ and 1.7% are multi-organ agers. +4 more findings

  10. 2023-12-05

    Multiphase optimization of a multicomponent intervention for informal dementia caregivers: a study protocol

    ✓ Peer-reviewed Caregiving Trials

    Key finding: This is the first study adopting the multiphase optimisation strategy to identify the most active and engaging components of a psychological intervention for caregivers of patients with dementia. +4 more findings

  11. 2023-12-04

    A Blood Screening Test for Dementia with Lewy Bodies for Primary Care

    ✓ Peer-reviewed Biomarkers Journal of Alzheimer's disease & Parkinsonism

    Key finding: The proteomic profile discriminated DLB and PD from NC with an AUC (Area Under the Curve) of 0.96 with demographics of age, sex and education. +3 more findings

  12. 2023-12-04

    Blood-based biomarkers in Alzheimer's disease: Future directions for implementation

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: Current diagnostic pathways are heterogeneous, meaning many AD patients are missed while low-risk patients undergo unnecessary procedures. +4 more findings

  13. 2023-12-01

    Donanemab in Early Symptomatic Alzheimer’s Disease: Efficacy and Safety in TRAILBLAZER‐ALZ 2, a Phase 3 Randomized Clinical Trial

    ✓ Peer-reviewed Treatments Alzheimer s & Dementia

    Key finding: Donanemab treatment significantly slowed clinical progression at 76w and had a safety profile consistent with earlier studies. +4 more findings

  14. 2023-12 month only

    Dementia caregiver burdens predict overnight hospitalization and hospice utilization

    ✓ Peer-reviewed End-of-life care Palliative & supportive care

    Key finding: Alive PWD (n = 804) were 2.36 times more likely to have an overnight hospital stay (p = 0.004) and 1.96 times more likely to have multiple hospitalizations when caregivers found it physically difficult to provide care (p = 0.011). +4 more findings

  15. 2023-12-01

    The Association Between Exposure to Air Pollution and Dementia Incidence: The Modifying Effect of Smoking

    ✓ Peer-reviewed Risk factors The journals of gerontology. Series A, Biological sciences and medical sciences

    Key finding: During a median 11.7 years follow-up, 5 905 incident cases of all-cause dementia were identified. +4 more findings

  16. 2023-12-01

    [18F]PI-2620 Binding Patterns in Patients with Suspected Alzheimer Disease and Frontotemporal Lobar Degeneration

    ✓ Peer-reviewed Brain scans and imaging Journal of nuclear medicine : official publication, Society of Nuclear Medicine

    Key finding: Patients with suspected AD neuropathology (Aβ-positive patients with mild cognitive impairment or AD dementia) showed high-intensity temporoparietal cortex-predominant [18F]PI-2620 binding. +4 more findings

  17. 2023-12-01

    Microbiota from Alzheimer's patients induce deficits in cognition and hippocampal neurogenesis

    ✓ Peer-reviewed Disease mechanisms Brain : a journal of neurology

    Key finding: We found impairments in behaviours reliant on adult hippocampal neurogenesis, an essential process for certain memory functions and mood, resulting from Alzheimer's patient transplants. +2 more findings

  18. 2023-12-01

    Cluster‐Derived Psychosocial Phenotypes, Cognitive Outcomes, and AD Plasma Biomarkers of Black and Hispanic/Latino Older Adults Enrolled in HABS‐HD

    ✓ Peer-reviewed Risk factors Alzheimer s & Dementia

    Key finding: The cluster analysis identified 3 distinct groups: Group 1 was low resource/high distress (n = 215); Group 2 was high resource/low distress (n = 248); and Group 3 was low resource/low distress (n = 353; Figure 1). +4 more findings

  19. 2023-12-01

    CHARACTERISTICS AND CARE EXPERIENCES OF OLDER DUAL-ENROLLEES LIVING IN AREAS WITH MEDICAID MANAGED LTSS

    ✓ Peer-reviewed Risk factors Innovation in Aging

    Key finding: Medicaid-funded long-term services and supports (LTSS) are foundational in helping older dual-enrollees with disabilities remain in the community. +1 more finding

  20. 2023-12-01

    Effects of structural and social determinants of health and comorbidities on ethno‐racial differences in ATN plasma biomarkers of Alzheimer’s disease: A HABS‐HD study

    ✓ Peer-reviewed Risk factors Alzheimer s & Dementia

    Key finding: Using a large and diverse community‐based cohort, we demonstrate that ethno‐racial differences in AD‐specific plasma biomarkers are, in part, due to modifiable health and comorbidity factors. +1 more finding

  21. 2023-12-01

    “Taxes, death, and trouble”: Role of structural socioeconomic racism on cognitive function for persons racialized as Black

    ✓ Peer-reviewed Risk factors Alzheimer s & Dementia

    Key finding: Participants racialized as Black who lived in places with higher levels of area‐level structural socioeconomic racism experienced lower levels of cognition at baseline and at varying time points in the six‐year period—compared to those in places with lower structural socioeconomic racism. +1 more finding

  22. 2023-12-01

    Disparities in Research Participation within a Multi‐Racial SARS‐CoV‐2 Cohort for Evaluation of Ultrahigh Field (7T) MRI and Clinical Precursors of Alzheimer’s Disease and Related Dementias

    ✓ Peer-reviewed Risk factors Alzheimer s & Dementia

    Key finding: It is imperative to recognize and mitigate persistent disparities in the COVID‐19 pandemic, particularly pertaining to participation in long‐COVID research. +4 more findings

  23. 2023-12-01
  24. 2023-12-01

    “The place where danger waits”: Ten years of the 1994 Crime Bill incarceration on cognitive function in older adults racialized as Black

    ✓ Peer-reviewed Risk factors Alzheimer s & Dementia

    Key finding: Ten‐year Black‐White disparities in prison population are associated with cognitive decline among people racialized as Black starting one year later. +4 more findings

  25. 2023-12-01

    Navigational Decision‐Making Among Older Drivers: An Analysis of Real‐World Driving Patterns

    ✓ Peer-reviewed Risk factors Alzheimer s & Dementia

    Key finding: This study reveals significant differences in driving patterns between cognitively normal older adults and those with cognitive impairment. +4 more findings

Browse the library by subject, with the full score breakdown →